Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q62587888
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235807.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q62587888
|
024
|
|
|
‡a
0000-0002-3361-6974
‡2
orcid
|
024
|
|
|
‡a
6701718262
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q62587888
|
100
|
0 |
|
‡a
Carmen M Martin-Ruiz
‡c
researcher
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Carmen M Martin-Ruiz
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's 25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study
|
670
|
|
|
‡a
Author's A meta-analysis of genome-wide association studies identifies multiple longevity genes
|
670
|
|
|
‡a
Author's A senescent cell bystander effect: senescence-induced senescence
|
670
|
|
|
‡a
Author's Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study.
|
670
|
|
|
‡a
Author's Age-related frailty and its association with biological markers of ageing
|
670
|
|
|
‡a
Author's Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936.
|
670
|
|
|
‡a
Author's Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study
|
670
|
|
|
‡a
Author's Association of mitochondrial haplogroup J and mtDNA oxidative damage in two different North Spain elderly populations
|
670
|
|
|
‡a
Author's Biomarkers of healthy ageing: expectations and validation
|
670
|
|
|
‡a
Author's Brood size moderates associations between relative size, telomere length, and immune development in European starling nestlings
|
670
|
|
|
‡a
Author's Characterization and isolation of SOB2, a human sperm protein with a potential role in oocyte membrane binding
|
670
|
|
|
‡a
Author's Childhood growth, IQ and education as predictors of white blood cell telomere length at age 49-51 years: the Newcastle Thousand Families Study
|
670
|
|
|
‡a
Author's CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study
|
670
|
|
|
‡a
Author's Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
|
670
|
|
|
‡a
Author's DNA damage response and cellular senescence in tissues of aging mice
|
670
|
|
|
‡a
Author's Early-life adversity accelerates cellular ageing and affects adult inflammation: Experimental evidence from the European starling.
|
670
|
|
|
‡a
Author's Elevated total Homocysteine in all Participants and Plasma Vitamin B12 Concentrations in Women are Associated with all-cause and Cardiovascular Mortality in the Very Old: The Newcastle 85+ Study.
|
670
|
|
|
‡a
Author's Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length.
|
670
|
|
|
‡a
Author's Frailty and mortality are not influenced by mitochondrial DNA haplotypes in the very old.
|
670
|
|
|
‡a
Author's Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study.
|
670
|
|
|
‡a
Author's Gender and telomere length: systematic review and meta-analysis
|
670
|
|
|
‡a
Author's Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age.
|
670
|
|
|
‡a
Author's Grip strength and inflammatory biomarker profiles in very old adults.
|
670
|
|
|
‡a
Author's Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study
|
670
|
|
|
‡a
Author's High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.
|
670
|
|
|
‡a
Author's Homocysteine, Tryptophan, and Cognition in the Very Old.
|
670
|
|
|
‡a
Author's Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians
|
670
|
|
|
‡a
Author's Inflammation, telomere length, and grip strength: a 10-year longitudinal study
|
670
|
|
|
‡a
Author's Intakes of Folate and Vitamin B12 and Biomarkers of Status in the Very Old: The Newcastle 85+ Study.
|
670
|
|
|
‡a
Author's Is Southern blotting necessary to measure telomere length reproducibly? Authors' Response to: Commentary: The reliability of telomere length measurements
|
670
|
|
|
‡a
Author's Longitudinal telomere length shortening and cognitive and physical decline in later life: The Lothian Birth Cohorts 1936 and 1921.
|
670
|
|
|
‡a
Author's Molecular analysis of nicotinic receptor expression in autism.
|
670
|
|
|
‡a
Author's Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients
|
670
|
|
|
‡a
Author's Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
|
670
|
|
|
‡a
Author's Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.
|
670
|
|
|
‡a
Author's No association between socio-economic status and white blood cell telomere length.
|
670
|
|
|
‡a
Author's O1.6. TELOMERE LENGTH IS ASSOCIATED WITH CHILDHOOD TRAUMA IN PATIENTS WITH SEVERE MENTAL DISORDERS
|
670
|
|
|
‡a
Author's One-Carbon Metabolism Biomarkers and Cognitive Decline in the Very Old: The Newcastle 85+ Study
|
670
|
|
|
‡a
Author's Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease
|
670
|
|
|
‡a
Author's Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease
|
670
|
|
|
‡a
Author's Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias
|
670
|
|
|
‡a
Author's Plasma Vitamin B12, Supplementation and Mortality
|
670
|
|
|
‡a
Author's Premature senescence of mesothelial cells is associated with non-telomeric DNA damage
|
670
|
|
|
‡a
Author's Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort
|
670
|
|
|
‡a
Author's Reactive oxygen species production and mitochondrial dysfunction in white blood cells are not valid biomarkers of ageing in the very old
|
670
|
|
|
‡a
Author's Reproducibility of telomere length assessment: an international collaborative study
|
670
|
|
|
‡a
Author's Reproducibility of telomere length assessment: Authors' Response to Damjan Krstajic and Ljubomir Buturovic
|
670
|
|
|
‡a
Author's RIPOSTE: a framework for improving the design and analysis of laboratory-based research
|
670
|
|
|
‡a
Author's Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study
|
670
|
|
|
‡a
Author's Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study.
|
670
|
|
|
‡a
Author's Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
|
670
|
|
|
‡a
Author's Short telomere length is associated with impaired cognitive performance in European ancestry cohorts.
|
670
|
|
|
‡a
Author's Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span
|
670
|
|
|
‡a
Author's Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response.
|
670
|
|
|
‡a
Author's Telomere length and aging biomarkers in 70-year-olds: the Lothian Birth Cohort 1936.
|
670
|
|
|
‡a
Author's Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study.
|
670
|
|
|
‡a
Author's Telomere length and physical performance at older ages: an individual participant meta-analysis
|
670
|
|
|
‡a
Author's Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study.
|
670
|
|
|
‡a
Author's Telomere length is associated with childhood trauma in patients with severe mental disorders
|
670
|
|
|
‡a
Author's Telomere length predicts poststroke mortality, dementia, and cognitive decline.
|
670
|
|
|
‡a
Author's Telomeres as biomarkers for ageing and age-related diseases.
|
670
|
|
|
‡a
Author's The epigenetic clock and telomere length are independently associated with chronological age and mortality
|
670
|
|
|
‡a
Author's The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol.
|
670
|
|
|
‡a
Author's Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.
|
909
|
|
|
‡a
(orcid) 0000000233616974
‡9
1
|
909
|
|
|
‡a
(scopus) 6701718262
‡9
1
|
912
|
|
|
‡a
metaanalysisofgenomewideassociationstudiesidentifiesmultiplelongevitygenes
‡A
A meta-analysis of genome-wide association studies identifies multiple longevity genes
‡9
1
|
912
|
|
|
‡a
genomewideassociationmetaanalysisofhumanlongevityidentifiesanovellocusconferringsurvivalbeyond90yearsofage
‡A
Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age.
‡9
1
|
919
|
|
|
‡a
25hydroxyvitamin500andincreasedallcausemortalityinveryoldwomenthenewcastle85+study
‡A
25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study
‡9
1
|
919
|
|
|
‡a
senescentcellbystandereffectsenescenceinducedsenescence
‡A
A senescent cell bystander effect: senescence-induced senescence
‡9
1
|
919
|
|
|
‡a
acquisitionofaberrantdnamethylationisassociatedwithfrailtyintheveryoldfindingsfromthenewcastle85+study
‡A
Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ Study.
‡9
1
|
919
|
|
|
‡a
agerelatedfrailtyanditsassociationwithbiologicalmarkersofageing
‡A
Age-related frailty and its association with biological markers of ageing
‡9
1
|
919
|
|
|
‡a
agerelatedgeneexpressionchangesandtranscriptomewideassociationstudyofphysicalandcognitiveagingtraitsinthelothianbirthcohort
‡A
Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936.
‡9
1
|
919
|
|
|
‡a
assessmentofalargepanelofcandidatebiomarkersofageinginthenewcastle85+study
‡A
Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study
‡9
1
|
919
|
|
|
‡a
associationofmitochondrialhaplogroupjandmtdnaoxidativedamagein2differentnorthspainelderlypopulations
‡A
Association of mitochondrial haplogroup J and mtDNA oxidative damage in two different North Spain elderly populations
‡9
1
|
919
|
|
|
‡a
biomarkersofhealthyageingexpectationsandvalidation
‡A
Biomarkers of healthy ageing: expectations and validation
‡9
1
|
919
|
|
|
‡a
broodsizemoderatesassociationsbetweenrelativesizetelomerelengthandimmunedevelopmentineuropeanstarlingnestlings
‡A
Brood size moderates associations between relative size, telomere length, and immune development in European starling nestlings
‡9
1
|
919
|
|
|
‡a
characterizationandisolationofsob2ahumanspermproteinwithapotentialroleinoocytemembranebinding
‡A
Characterization and isolation of SOB2, a human sperm protein with a potential role in oocyte membrane binding
‡9
1
|
919
|
|
|
‡a
childhoodgrowthiqandeducationaspredictorsofwhitebloodcelltelomerelengthatage4951yearsthenewcastlethousandfamiliesstudy
‡A
Childhood growth, IQ and education as predictors of white blood cell telomere length at age 49-51 years: the Newcastle Thousand Families Study
‡9
1
|
919
|
|
|
‡a
905seropositivityandtcellsenescencepredictincreasedcardiovascularmortalityinoctogenariansresultsfromthenewcastle85+study
‡A
CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study
‡9
1
|
919
|
|
|
‡a
dementiaratingandnicotinicreceptorexpressionintheprefrontalcortexinschizophrenia
‡A
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
‡9
1
|
919
|
|
|
‡a
dnadamageresponseandcellularsenescenceintissuesofagingmice
‡A
DNA damage response and cellular senescence in tissues of aging mice
‡9
1
|
919
|
|
|
‡a
earlylifeadversityacceleratescellularageingandaffectsadultinflammationexperimentalevidencefromtheeuropeanstarling
‡A
Early-life adversity accelerates cellular ageing and affects adult inflammation: Experimental evidence from the European starling.
‡9
1
|
919
|
|
|
‡a
elevatedtotalhomocysteineinallparticipantsandplasmavitaminb12concentrationsinwomenareassociatedwithallcauseandcardiovascularmortalityintheveryoldthenewcastle85+study
‡A
Elevated total Homocysteine in all Participants and Plasma Vitamin B12 Concentrations in Women are Associated with all-cause and Cardiovascular Mortality in the Very Old: The Newcastle 85+ Study.
‡9
1
|
919
|
|
|
‡a
endometriosisisassociatedwithaberrantendometrialexpressionoftelomeraseandincreasedtelomerelength
‡A
Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length.
‡9
1
|
919
|
|
|
‡a
frailtyandmortalityarenotinfluencedbymitochondrialdnahaplotypesintheveryold
‡A
Frailty and mortality are not influenced by mitochondrial DNA haplotypes in the very old.
‡9
1
|
919
|
|
|
‡a
frailtyandtheroleofinflammationimmunosenescenceandcellularageingintheveryoldcrosssectionalfindingsfromthenewcastle85+study
‡A
Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study.
‡9
1
|
919
|
|
|
‡a
genderandtelomerelengthsystematicreviewandmetaanalysis
‡A
Gender and telomere length: systematic review and meta-analysis
‡9
1
|
919
|
|
|
‡a
gripstrengthandinflammatorybiomarkerprofilesinveryoldadults
‡A
Grip strength and inflammatory biomarker profiles in very old adults.
‡9
1
|
919
|
|
|
‡a
healthanddiseasein85yearoldsbaselinefindingsfromthenewcastle85+cohortstudy
‡A
Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study
‡9
1
|
919
|
|
|
‡a
highthroughput13parameterimmunophenotypingidentifiesshiftsinthecirculatingtcellcompartmentfollowingreperfusioninpatientswithacutemyocardialinfarction
‡A
High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.
‡9
1
|
919
|
|
|
‡a
homocysteinetryptophanandcognitionintheveryold
‡A
Homocysteine, Tryptophan, and Cognition in the Very Old.
‡9
1
|
919
|
|
|
‡a
inflammationbutnottelomerelengthpredictssuccessfulageingatextremeoldagealongitudinalstudyofsemisupercentenarians
‡A
Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians
‡9
1
|
919
|
|
|
‡a
inflammationtelomerelengthandgripstrengtha10yearlongitudinalstudy
‡A
Inflammation, telomere length, and grip strength: a 10-year longitudinal study
‡9
1
|
919
|
|
|
‡a
intakesoffolateandvitaminb12andbiomarkersofstatusintheveryoldthenewcastle85+study
‡A
Intakes of Folate and Vitamin B12 and Biomarkers of Status in the Very Old: The Newcastle 85+ Study.
‡9
1
|
919
|
|
|
‡a
issouthernblottingnecessarytomeasuretelomerelengthreproduciblyauthorsresponsetocommentarythereliabilityoftelomerelengthmeasurements
‡A
Is Southern blotting necessary to measure telomere length reproducibly? Authors' Response to: Commentary: The reliability of telomere length measurements
‡9
1
|
919
|
|
|
‡a
longitudinaltelomerelengthshorteningandcognitiveandphysicaldeclineinlaterlifethelothianbirthcohorts1936and
‡A
Longitudinal telomere length shortening and cognitive and physical decline in later life: The Lothian Birth Cohorts 1936 and 1921.
‡9
1
|
919
|
|
|
‡a
molecularanalysisofnicotinicreceptorexpressioninautism
‡A
Molecular analysis of nicotinic receptor expression in autism.
‡9
1
|
919
|
|
|
‡a
myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescencein905seropositivepatients
‡A
Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients
‡9
1
|
919
|
|
|
‡a
neuropathologicallymixedalzheimersandlewybodydiseaseburdenofpathologicalproteinaggregatesdiffersbetweenclinicalphenotypes
‡A
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
‡9
1
|
919
|
|
|
‡a
nicotinicreceptorsintheputamenofpatientswithdementiawithlewybodiesandparkinsonsdiseaserelationtochangesinalphasynucleinexpression
‡A
Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.
‡9
1
|
919
|
|
|
‡a
noassociationbetweensocioeconomicstatusandwhitebloodcelltelomerelength
‡A
No association between socio-economic status and white blood cell telomere length.
‡9
1
|
919
|
|
|
‡a
o16telomerelengthisassociatedwithchildhoodtraumainpatientswithseverementaldisorders
‡A
O1.6. TELOMERE LENGTH IS ASSOCIATED WITH CHILDHOOD TRAUMA IN PATIENTS WITH SEVERE MENTAL DISORDERS
‡9
1
|
919
|
|
|
‡a
1carbonmetabolismbiomarkersandcognitivedeclineintheveryoldthenewcastle85+study
‡A
One-Carbon Metabolism Biomarkers and Cognitive Decline in the Very Old: The Newcastle 85+ Study
‡9
1
|
919
|
|
|
‡a
parietalwhitematterlesionsinalzheimersdiseaseareassociatedwithcorticalneurodegenerativepathologybutnotwithsmallvesseldisease
‡A
Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease
‡9
1
|
919
|
|
|
‡a
peripheralinflammationinmildcognitiveimpairmentwithpossibleandprobablelewybodydiseaseandalzheimersdisease
‡A
Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease
‡9
1
|
919
|
|
|
‡a
peripheralinflammationinprodromalalzheimersandlewybodydementias
‡A
Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias
‡9
1
|
919
|
|
|
‡a
plasmavitaminb12supplementationandmortality
‡A
Plasma Vitamin B12, Supplementation and Mortality
‡9
1
|
919
|
|
|
‡a
prematuresenescenceofmesothelialcellsisassociatedwithnontelomericdnadamage
‡A
Premature senescence of mesothelial cells is associated with non-telomeric DNA damage
‡9
1
|
919
|
|
|
‡a
rateoftelomereshorteningandcardiovasculardamagealongitudinalstudyinthe1946britishbirthcohort
‡A
Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort
‡9
1
|
919
|
|
|
‡a
reactiveoxygenspeciesproductionandmitochondrialdysfunctioninwhitebloodcellsarenotvalidbiomarkersofageingintheveryold
‡A
Reactive oxygen species production and mitochondrial dysfunction in white blood cells are not valid biomarkers of ageing in the very old
‡9
1
|
919
|
|
|
‡a
reproducibilityoftelomerelengthassessmentaninternationalcollaborativestudy
‡A
Reproducibility of telomere length assessment: an international collaborative study
‡9
1
|
919
|
|
|
‡a
reproducibilityoftelomerelengthassessmentauthorsresponsetodamjankrstajicandljubomirbuturovic
‡A
Reproducibility of telomere length assessment: Authors' Response to Damjan Krstajic and Ljubomir Buturovic
‡9
1
|
919
|
|
|
‡a
riposteaframeworkforimprovingthedesignandanalysisoflaboratorybasedresearch
‡A
RIPOSTE: a framework for improving the design and analysis of laboratory-based research
‡9
1
|
919
|
|
|
‡a
serum25hydroxyvitamin500andcognitivedeclineintheveryoldthenewcastle85+study
‡A
Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study
‡9
1
|
919
|
|
|
‡a
serum25hydroxyvitamin500concentrationanditsdeterminantsintheveryoldthenewcastle85+study
‡A
Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study.
‡9
1
|
919
|
|
|
‡a
serumthyroidfunctionmortalityanddisabilityinadvancedoldagethenewcastle85+study
‡A
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
‡9
1
|
919
|
|
|
‡a
shorttelomerelengthisassociatedwithimpairedcognitiveperformanceineuropeanancestrycohorts
‡A
Short telomere length is associated with impaired cognitive performance in European ancestry cohorts.
‡9
1
|
919
|
|
|
‡a
stochasticvariationintelomereshorteningratecausesheterogeneityofhumanfibroblastreplicativelifespan
‡A
Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span
‡9
1
|
919
|
|
|
‡a
sustainedreplicationinendometriumofwomenwithendometriosisoccurswithoutevokingadnadamageresponse
‡A
Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response.
‡9
1
|
919
|
|
|
‡a
telomerelengthandagingbiomarkersin70yearoldsthelothianbirthcohort
‡A
Telomere length and aging biomarkers in 70-year-olds: the Lothian Birth Cohort 1936.
‡9
1
|
919
|
|
|
‡a
telomerelengthandanaemiainoldageresultsfromthenewcastle85plusstudyandtheleiden85plusstudy
‡A
Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study.
‡9
1
|
919
|
|
|
‡a
telomerelengthandphysicalperformanceatolderagesanindividualparticipantmetaanalysis
‡A
Telomere length and physical performance at older ages: an individual participant meta-analysis
‡9
1
|
919
|
|
|
‡a
telomerelengthinwhitebloodcellsisnotassociatedwithmorbidityormortalityintheoldestoldapopulationbasedstudy
‡A
Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study.
‡9
1
|
919
|
|
|
‡a
telomerelengthisassociatedwithchildhoodtraumainpatientswithseverementaldisorders
‡A
Telomere length is associated with childhood trauma in patients with severe mental disorders
‡9
1
|
919
|
|
|
‡a
telomerelengthpredictspoststrokemortalitydementiaandcognitivedecline
‡A
Telomere length predicts poststroke mortality, dementia, and cognitive decline.
‡9
1
|
919
|
|
|
‡a
telomeresasbiomarkersforageingandagerelateddiseases
‡A
Telomeres as biomarkers for ageing and age-related diseases.
‡9
1
|
919
|
|
|
‡a
epigeneticclockandtelomerelengthareindependentlyassociatedwithchronologicalageandmortality
‡A
The epigenetic clock and telomere length are independently associated with chronological age and mortality
‡9
1
|
919
|
|
|
‡a
newcastle85+studybiologicalclinicalandpsychosocialfactorsassociatedwithhealthyageingstudyprotocol
‡A
The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol.
‡9
1
|
919
|
|
|
‡a
utilityofntprobnpasaruleouttestforleftventriculardysfunctioninveryoldpeoplewithlimitingdyspnoeathenewcastle85+study
‡A
Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.
‡9
1
|
943
|
|
|
‡a
193x
‡A
1936
‡9
2
|
943
|
|
|
‡a
192x
‡A
1921
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
RERO|A018858894
|
996
|
|
|
‡2
BNC|981058614179206706
|
996
|
|
|
‡2
NTA|153267011
|
996
|
|
|
‡2
BNE|XX1458241
|
996
|
|
|
‡2
BNE|XX839159
|
996
|
|
|
‡2
NKC|jx20050524007
|
996
|
|
|
‡2
BNE|XX5203409
|
996
|
|
|
‡2
BNE|XX1715828
|
996
|
|
|
‡2
BNE|XX1758587
|
996
|
|
|
‡2
BNE|XX4838228
|
996
|
|
|
‡2
ISNI|0000000031430581
|
996
|
|
|
‡2
LC|n 97097638
|
996
|
|
|
‡2
LC|no2022025211
|
996
|
|
|
‡2
NTA|344732886
|
996
|
|
|
‡2
ISNI|0000000118284441
|
996
|
|
|
‡2
BIBSYS|9006333
|
996
|
|
|
‡2
ISNI|0000000059884593
|
996
|
|
|
‡2
PTBNP|1056382
|
996
|
|
|
‡2
PTBNP|1684421
|
996
|
|
|
‡2
DNB|1157342795
|
996
|
|
|
‡2
BNE|XX848332
|
996
|
|
|
‡2
BNF|17840235
|
996
|
|
|
‡2
SUDOC|24078586X
|
996
|
|
|
‡2
BNC|981058512968506706
|
996
|
|
|
‡2
BNE|XX4580128
|
996
|
|
|
‡2
NYNYRILM|65324
|
996
|
|
|
‡2
DNB|1141708973
|
996
|
|
|
‡2
BNCHL|10000000000000000007738
|
996
|
|
|
‡2
SUDOC|235631108
|
996
|
|
|
‡2
SUDOC|243338422
|
996
|
|
|
‡2
LC|nb2011018775
|
996
|
|
|
‡2
LC|n 2006076811
|
996
|
|
|
‡2
DNB|1047964880
|
996
|
|
|
‡2
BNCHL|10000000000000000089050
|
996
|
|
|
‡2
SUDOC|074451286
|
996
|
|
|
‡2
BNE|XX1784771
|
996
|
|
|
‡2
BNF|12783865
|
996
|
|
|
‡2
BNF|13532447
|
996
|
|
|
‡2
BNE|XX1537789
|
996
|
|
|
‡2
DNB|1057514500
|
996
|
|
|
‡2
DNB|1282581619
|
996
|
|
|
‡2
BNF|16248265
|
996
|
|
|
‡2
DNB|1057246360
|
996
|
|
|
‡2
DNB|127437622
|
996
|
|
|
‡2
LC|n 2018040931
|
996
|
|
|
‡2
LC|no2017074336
|
996
|
|
|
‡2
BIBSYS|90839906
|
996
|
|
|
‡2
NTA|070292434
|
996
|
|
|
‡2
BNC|981058620350506706
|
996
|
|
|
‡2
BAV|495_366259
|
996
|
|
|
‡2
BNE|XX5063128
|
996
|
|
|
‡2
BNE|XX1021615
|
996
|
|
|
‡2
NKC|jcu2011659206
|
996
|
|
|
‡2
BNC|981058511027906706
|
996
|
|
|
‡2
SUDOC|172295386
|
996
|
|
|
‡2
BNC|981058513904906706
|
996
|
|
|
‡2
BNE|XX1064668
|
996
|
|
|
‡2
ISNI|0000000010726455
|
996
|
|
|
‡2
BIBSYS|14067563
|
996
|
|
|
‡2
BNCHL|10000000000000000207793
|
996
|
|
|
‡2
ISNI|0000000121455280
|
996
|
|
|
‡2
LC|n 2012008611
|
996
|
|
|
‡2
LC|n 84219146
|
996
|
|
|
‡2
BNC|981058617835806706
|
996
|
|
|
‡2
SUDOC|059558865
|
996
|
|
|
‡2
ISNI|0000000061012006
|
996
|
|
|
‡2
BNE|XX4862661
|
996
|
|
|
‡2
SUDOC|060860928
|
996
|
|
|
‡2
BNC|981058616051106706
|
996
|
|
|
‡2
ARBABN|000043086
|
996
|
|
|
‡2
BNC|981058528418706706
|
996
|
|
|
‡2
SUDOC|169278115
|
996
|
|
|
‡2
ISNI|000000006099866X
|
996
|
|
|
‡2
DNB|1054821623
|
996
|
|
|
‡2
RERO|A005987061
|
996
|
|
|
‡2
ISNI|0000000121489413
|
996
|
|
|
‡2
ISNI|0000000077042031
|
996
|
|
|
‡2
LC|n 79109722
|
996
|
|
|
‡2
BNE|XX4806308
|
996
|
|
|
‡2
ISNI|0000000513265304
|
996
|
|
|
‡2
DNB|1154816214
|
996
|
|
|
‡2
SUDOC|274928922
|
996
|
|
|
‡2
ISNI|0000000059483722
|
996
|
|
|
‡2
ISNI|000000050104669X
|
996
|
|
|
‡2
SUDOC|055793819
|
996
|
|
|
‡2
RERO|A003770509
|
996
|
|
|
‡2
LC|n 96019665
|
996
|
|
|
‡2
DNB|1027971466
|
996
|
|
|
‡2
BNF|12398819
|
996
|
|
|
‡2
ISNI|0000000060096885
|
996
|
|
|
‡2
LC|n 2001028163
|
996
|
|
|
‡2
SUDOC|059930624
|
996
|
|
|
‡2
BNE|XX5547566
|
996
|
|
|
‡2
BNE|XX4781711
|
996
|
|
|
‡2
RERO|A003607500
|
996
|
|
|
‡2
DNB|1056759216
|
996
|
|
|
‡2
BNE|XX5732417
|
996
|
|
|
‡2
LC|n 99039513
|
996
|
|
|
‡2
BNC|981058611767406706
|
996
|
|
|
‡2
BNE|XX1398876
|
996
|
|
|
‡2
BNE|XX1791468
|
996
|
|
|
‡2
SUDOC|244870616
|
996
|
|
|
‡2
DNB|105667654X
|
996
|
|
|
‡2
SUDOC|13976786X
|
996
|
|
|
‡2
ISNI|0000000060440607
|
996
|
|
|
‡2
NUKAT|n 2016082138
|
996
|
|
|
‡2
NSK|000468208
|
996
|
|
|
‡2
NII|DA08631027
|
996
|
|
|
‡2
BNE|XX884123
|
996
|
|
|
‡2
BAV|495_116048
|
996
|
|
|
‡2
NKC|xx0240463
|
996
|
|
|
‡2
SUDOC|256599599
|
996
|
|
|
‡2
ISNI|0000000059492426
|
996
|
|
|
‡2
ISNI|0000000070194526
|
996
|
|
|
‡2
DNB|1057345822
|
996
|
|
|
‡2
SUDOC|033086222
|
996
|
|
|
‡2
BNC|981058522519006706
|
996
|
|
|
‡2
BNE|XX879857
|
996
|
|
|
‡2
NUKAT|n 2015097433
|
996
|
|
|
‡2
BNC|981060734772806706
|
996
|
|
|
‡2
BIBSYS|90088006
|
996
|
|
|
‡2
J9U|987007351532105171
|
996
|
|
|
‡2
DNB|1157164633
|
996
|
|
|
‡2
ISNI|0000000059869289
|
996
|
|
|
‡2
BNE|XX5430095
|
996
|
|
|
‡2
BNCHL|10000000000000000038366
|
996
|
|
|
‡2
RERO|A016287605
|
996
|
|
|
‡2
LC|nb2010012315
|
996
|
|
|
‡2
BNE|XX1761921
|
996
|
|
|
‡2
ISNI|000000011837499X
|
996
|
|
|
‡2
BNC|981060788849906706
|
996
|
|
|
‡2
SUDOC|085860492
|
996
|
|
|
‡2
BNE|XX4828482
|
996
|
|
|
‡2
SUDOC|279358733
|
996
|
|
|
‡2
LC|no2014019243
|
996
|
|
|
‡2
SUDOC|155049194
|
996
|
|
|
‡2
NKC|jo2013781209
|
996
|
|
|
‡2
NII|DA15768145
|
996
|
|
|
‡2
ISNI|0000000032092414
|
996
|
|
|
‡2
BNE|XX1031632
|
996
|
|
|
‡2
ISNI|0000000059484354
|
996
|
|
|
‡2
NTA|302352880
|
996
|
|
|
‡2
LC|n 2023034616
|
996
|
|
|
‡2
BNE|XX1054129
|
996
|
|
|
‡2
LC|n 94026831
|
996
|
|
|
‡2
ISNI|0000000079775976
|
996
|
|
|
‡2
LC|n 82045779
|
996
|
|
|
‡2
ISNI|0000000061147074
|
996
|
|
|
‡2
BNE|XX956536
|
996
|
|
|
‡2
ISNI|0000000081461140
|
996
|
|
|
‡2
BNF|16525722
|
996
|
|
|
‡2
NSK|000781037
|
996
|
|
|
‡2
RERO|A028853430
|
996
|
|
|
‡2
SUDOC|152913750
|
996
|
|
|
‡2
BIBSYS|1630354429749
|
996
|
|
|
‡2
SUDOC|224526383
|
996
|
|
|
‡2
ISNI|0000000108378217
|
996
|
|
|
‡2
BNF|17761211
|
996
|
|
|
‡2
BIBSYS|90587646
|
996
|
|
|
‡2
DNB|1158606060
|
996
|
|
|
‡2
NSK|000588951
|
996
|
|
|
‡2
RERO|A003680984
|
996
|
|
|
‡2
NSK|000405160
|
996
|
|
|
‡2
PTBNP|1674090
|
996
|
|
|
‡2
NUKAT|n 2014167242
|
996
|
|
|
‡2
PTBNP|1550728
|
996
|
|
|
‡2
NII|DA04000931
|
996
|
|
|
‡2
BNE|XX844367
|
996
|
|
|
‡2
DNB|1100065431
|
996
|
|
|
‡2
ISNI|0000000115660341
|
996
|
|
|
‡2
DNB|1057471364
|
996
|
|
|
‡2
BNE|XX5467704
|
996
|
|
|
‡2
BNE|XX856246
|
996
|
|
|
‡2
NKC|xx0215287
|
996
|
|
|
‡2
SUDOC|276384490
|
996
|
|
|
‡2
BNC|981059731759306706
|
996
|
|
|
‡2
LC|ns2024001272
|
996
|
|
|
‡2
ISNI|0000000059335471
|
996
|
|
|
‡2
NUKAT|n 97006568
|
996
|
|
|
‡2
BNE|XX962213
|
996
|
|
|
‡2
LC|no2022026808
|
996
|
|
|
‡2
ISNI|0000000079526152
|
996
|
|
|
‡2
BNE|XX860761
|
996
|
|
|
‡2
NDL|00682194
|
996
|
|
|
‡2
LC|n 2018036852
|
996
|
|
|
‡2
DNB|138439222
|
996
|
|
|
‡2
BNC|981058516411706706
|
996
|
|
|
‡2
BNE|XX1089951
|
996
|
|
|
‡2
BNE|XX851061
|
996
|
|
|
‡2
PTBNP|1600923
|
996
|
|
|
‡2
BNCHL|10000000000000000842655
|
996
|
|
|
‡2
DNB|1089702531
|
996
|
|
|
‡2
BNE|XX842801
|
996
|
|
|
‡2
SUDOC|185611575
|
996
|
|
|
‡2
LC|no2018170040
|
996
|
|
|
‡2
BNC|981058507870306706
|
996
|
|
|
‡2
SUDOC|200541714
|
996
|
|
|
‡2
BNE|XX1095512
|
996
|
|
|
‡2
CAOONL|ncf13698850
|
996
|
|
|
‡2
BNC|981058523082606706
|
996
|
|
|
‡2
BNE|XX5379308
|
996
|
|
|
‡2
ISNI|0000000018109232
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|